Fifth Eye’s AHI-PI Demonstrates Ability to Detect Patient Deterioration Prior to Rapid Response Team Events: New Study Published in PLOS Digital Health

Analytic for Hemodynamic Instability – Predictive Indicator (AHI-PI), from Weil Institute spin-off Fifth Eye, outperforms traditional vital sign measurements in early detection, offering a 26-hour lead time and expanding applications beyond the ICU.

General AnnouncementKate MurphyOctober 24, 2024AHI, Fifth Eye, Fifth Eye Inc-, Rapid Response, predictive analytic

Clinical study of ECG-based analytic shows average three-hour advance prediction of hemodynamic instability

The Analytic for Hemodynamic Instability (AHI) from Weil Institute partner Fifth Eye, Inc. provides clinically significant lead time in predicting onset of instability before vital signs.

Fifth Eye's AHI System™ for Predictive Patient Analytics Now Available in Medical Informatics Corp.'s Sickbay™ Platform

Fifth Eye's AHI System is the only FDA-cleared medical device software of its kind, detecting hemodynamic instability that can signal patient decompensation ahead of vital signs.

Study Shows Medical Device Software System Developed at U-M Could Provide Bridge to Surpass Limits of Traditional Vital Signs in Identifying Patient Deterioration

The Analytic for Hemodynamic Instability (AHI) detected the various gold standard measures of hemodynamic deterioration with high sensitivity and specificity, paving the way for further study into AHI’s potential as a surrogate measure of clinical status in settings where continuous monitoring of vital signs would not be possible.

Predictive analytic technology developed at MCIRCC gets $11.5 million investment

Michigan Medicine spinoff company receives the funding to commercialize the technology as its first product.

HIT Consultant: UM Spinout Fifth Eye Lands $11.5M for Early Warning Patient Deterioration System for Hospitals

Fifth Eye Inc. has raised $11.5 million in Series A funding led by Arboretum Ventures and Cultivation Capital. Other participants in the round included MINTS, the direct investing arm of the University of Michigan’s endowment, along with additional capital from previous investors Invest Michigan and 35 private angel investors.

Fifth Eye Press Release: https://fiftheye.com/wp-content/uploads/2019/03/fifth-eye-press-release-final.pdf

Xconomy: After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval

Fifth Eye Inc. raises total venture backing of $11.5M to secure FDA clearance for their first product, Analytic for Hemodynamic Instability!

Fifth Eye Press Release: https://fiftheye.com/wp-content/uploads/2019/03/fifth-eye-press-release-final.pdf

Crain's Detroit: UM Health Spinoff Fifth Eye Nabs $11M VC Round

Fifth Eye Inc. raises $11.5M Series A investment to secure FDA clearance for their first product, Analytic for Hemodynamic Instability!

Fifth Eye Press Release: https://fiftheye.com/wp-content/uploads/2019/03/fifth-eye-press-release-final.pdf

Latest News